Supplementation of Lactobacillus casei Reduces Beta-amyloid Accumulation in Alzheimer Drosophila melanogaster
ISEF · 2021 Animal Sciences Second Award
Overview
As the lifespan of humans increases, common chronic diseases of older people are becoming more prevalent, predominantly Alzheimer’s Disease (AD). AD is a condition where patients experience memory loss, decline in thinking abilities and personality changes. Characterised by the accumulation of beta-amyloid between neurons in the brain, AD detrimentally affects how neurons process and transmit information. Downfalls of current treatments include only mildly relieving symptoms of AD and high cost. As such, new possible treatments, especially the use of probiotics, have been becoming increasingly prominent to curtail AD. In this study, supplementation of dietary Lactobacillus casei (L. casei) was used to investigate its effect on AD in Drosophila melanogaster. Transgenic flies expressing beta-amyloid were fed different dosages of L. casei from eclosion to adulthood. Consequently, geotaxis assay, lifespan assay, rough eye phenotype assessment and brain imaging were performed to assess the effects of L.casei on AD flies. In a nutshell, it was found that supplementation of at least 6 x 104 cfu L.casei was effective in reducing the beta-amyloid accumulation as evidenced by the recovery of locomotion, extended lifespan, reduced eye degeneration and brain imaging. Ultimately, early consumption of L.casei has arisen as a promising treatment for AD due to its cost-effectiveness and easy accessibility, serving to benefit the masses. Current treatments have been limited to alleviating the symptoms of AD instead of addressing the underlying root of AD- the accumulation of beta-amyloid. With L.casei reducing beta-amyloid accumulation, AD patients could potentially make a full recovery.
Awards (1)
- Second Award of $2,000 $2,000
Competition history
- ISEF 2021
Resources
Related projects
ISEF · 2024
Elucidating the Impact of Lactobacillus casei ATCC 393 on Amyloid Plaque Generation in Alzheimer's Model Caenorhabditis elegans GRU102
ISEF · 2026
Modulation of Gamma-Aminobutyric Acid by Lactobacillus rhamnosus in Caenorhabditis elegans Modeling Alzheimer’s Disease
ISEF · 2017
Evaluating the Effects of Probiotics on Neurology in the Model Organism Drosophila melanogaster Adult Flies and Third Stage Instar Larvae Utilizing Environmental Stressors and Behavioral Assays
ISEF · 2026
The Effect of Dietary Phoenix dactylifera on Gut Microbial Composition and Memory in Drosophila melanogaster Expressing the Amyloid Precursor Protein (APP)
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair